MARIAN ZGODINSKI: Open Payments
NPI 1649739657 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,173 in 182 payments from 19 companies in 2025. Trend: 2023 $614 · 2024 $3,113 · 2025 $3,173
Food & beverage: $3,173
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $731 |
| Otsuka America Pharmaceutical, Inc. | 31 | $490 |
| Vanda Pharmaceuticals Inc. | 21 | $367 |
| Neos Therapeutics, LP | 17 | $286 |
| Axsome Therapeutics, Inc. | 13 | $282 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $267 |
| Collegium Pharmaceutical, Inc. | 9 | $142 |
| Lundbeck LLC | 5 | $105 |
| Alkermes, Inc. | 6 | $98 |
| Sage Therapeutics, LLC | 3 | $68 |
Products named: VRAYLAR, REXULTI, Auvelity, CAPLYTA, Adzenys XR-ODT, FANAPT, HETLIOZ, Jornay PM.
Industry payments across OH — which companies pay providers there.
